Log in to search using one of your social media accounts:

 

How integrative medicine eliminates the threat of cancer, without resorting to toxic treatments
(Natural News) According to the National Cancer Institute, one out of two men and one out of three women in the United States will develop cancer in their lifetime. (In other words, about 40 percent of the adult population will receive a cancer diagnosis at some point). This statistic (alone) should serve as a wake-up... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2018 Category: Consumer Health News Source Type: news

Spotlight on cancer-fighting foods: What to eat to beat different kinds of cancer
(Natural News) Dr. Michael Greger remarked in a Daily Mail article that the consumption of wholefood vegetarian diets can reduce the risks of various forms of cancer. “Food is the single greatest way our bodies face exposure to the outside environment,” explained the author of the 2016 bestseller “How Not To Die”. He warned about... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2018 Category: Consumer Health News Source Type: news

Roche acquires oncology EHR company Flatiron Health for $1.9B
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had already invested into the company in 2016, and as a result of the deal will control all shares of Flatiron Health. (Source: mobihealthnews)
Source: mobihealthnews - February 15, 2018 Category: Information Technology Source Type: news

Physical Therapy Improves Arm Mobility After Lymph Node Dissection Physical Therapy Improves Arm Mobility After Lymph Node Dissection
Guided exercise with a physical therapist after breast-cancer surgery to remove lymphatic tissue helps women quickly regain full range of arm motion, new research shows.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 15, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio
(Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held U.S. cancer data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patients. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Breast MRIs may lead to more biopsies that catch fewer cancers
(Reuters Health) - Women who get magnetic resonance imaging (MRI) screening tests for breast cancer are more likely to get invasive surgical biopsies to look for tumors than women who just get screening mammograms, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Bone Markers Can Predict Bone-Specific Recurrence in Early Breast Cancer
Several markers of bone formation and resorption were found to be predictive of bone-specific recurrence in patients with early breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

Overlooked Biomarker May Predict Cancer Immunotherapy Response Overlooked Biomarker May Predict Cancer Immunotherapy Response
Dr David Kerr on data showing that tumors with extensive aneuploidy may not benefit as much from immune checkpoint blockade.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Roche to buy Flatiron Health for $1.9 billion
(Reuters) - Drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held oncology data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patients. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

In mice, a single vaccine prompts the immune system to fight breast, lung and skin cancers
In the field of regenerative medicine, induced pluripotent stem cells have a lot of neat tricks up their sleeves. One of them may be teaching the immune system how to beat back cancer.In research that could open a new frontier in the young field of cancer immunotherapy, Stanford University scientists... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - February 15, 2018 Category: Science Authors: Melissa Healy Source Type: news

Girls can inherit deadly ovarian cancer gene from fathers
The mutation, which has not been named, was discovered in a genetic study of 186 women with ovarian cancer done by Roswell Park Cancer Institute in Buffalo, New York. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2018 Category: Consumer Health News Source Type: news

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer
Roche and Flatiron Health, Inc. announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6%. (Source: Roche Media News)
Source: Roche Media News - February 15, 2018 Category: Pharmaceuticals Source Type: news

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer
Roche and Flatiron Health, Inc. announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6%. (Source: Roche Investor Update)
Source: Roche Investor Update - February 15, 2018 Category: Pharmaceuticals Source Type: news

Rapid radiation therapy minimizes treatment time, improves quality of life
Faster treatment is possible for a variety of cancers, thanks to hypofractionated radiotherapy currently being employed by doctors at Yale Medicine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 15, 2018 Category: Universities & Medical Training Source Type: news

Fathers may pass ovarian cancer risk to daughters
Many cases of seemingly sporadic ovarian cancer might actually be inherited from paternal genes. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 15, 2018 Category: Consumer Health News Source Type: news

Beyond APHINITY: What Now After Pivotal Breast Cancer Trial? Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?
Dr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

CRISPR scissors, Cas12a, enable cutting-edge diagnostics
CRISPR research from the University of California might transform diagnostics. The scientists behind the new study are hopeful that it will speed up cancer and infectious disease diagnoses. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2018 Category: Consumer Health News Source Type: news

Stem cell cancer vaccine immunized mice against tumors
Researchers at Stanford University made personalized stem cell vaccines for mice. The stem cell shot, coupled with an immunity booster, shrank tumors in seven out of 10 of the mice. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2018 Category: Consumer Health News Source Type: news

Switzerland Wants to Ban Minors From Using Tanning Salons
(GENEVA) — Switzerland’s government says minors should be prohibited from using tanning salons because of the long-term risk that radiation from ultraviolet beds could cause skin cancer. The seven-member Federal Council took the position Wednesday as it invited public comment on a package of safety measures meant to protect the population from exposure to UV radiation and excessively loud noises. The proposals also include limiting medical lasers in cosmetic treatments and rules for electronic amplifiers at demonstrations, such as requiring organizers to provide ear protection if sound levels exceed an average ...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized APH Cancer healthytime onetime Source Type: news

Laryngovideostroboscopy Useful for Vocal Fold Lesion Screening
Narrow band imaging better for decision to biopsy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 15, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pathology, Journal, Source Type: news

Another Cancer Vaccine Shows Promise In Mice
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 15, 2018 Category: Cancer & Oncology Tags: Infections, Oncology, Research, News, Source Type: news

FDA clears Arterys Oncology AI suite
The U.S. Food and Drug Administration (FDA) has cleared imaging software developer...Read more on AuntMinnie.comRelated Reading: Arterys unveils Mica software at RSNA 2017 Arterys nets $30M in financing Arterys receives SIIM award for cloud project FDA OK's Arterys cardiac software Arterys nets FDA OK for 4D software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 15, 2018 Category: Radiology Source Type: news

Cancer cure HOPE: Vaccine can ‘train immune system to stop tumours developing’
CANCER claims thousands of lives in the UK every year, and awareness over symptoms is always being brought to the forefront. But an anti-cancer vaccine could soon be developed by scientists. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Have scientists found an anti-cancer vaccine?
Researchers used stem cells to create an anti-cancer vaccine, which they tested in 75 mice with various types of cancer. Here's what they found. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 15, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Thyroid Cancer Rates Are Rising For An Infuriating Reason
There's no evidence that physicians save lives by examining their patients'necks for lumps. But there is solid evidence that checking for lumps leads to diagnoses of non-threatening thyroid cancers. So why do do these exams continue? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 15, 2018 Category: Pharmaceuticals Authors: Peter Ubel, Contributor Tags: NASDAQ:GENZ Source Type: news

Novel De-escalation Approach for HPV+ Head and Neck Cancer Novel De-escalation Approach for HPV+ Head and Neck Cancer
A study of a novel approach to de-escalating treatment for HPV-positive head and neck cancer shows excellent pathologic complete response and survival outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
FDA clearance covers all solid tumors. Initial launch will include Liver AI and Lung AI oncology software to empower clinicians to quickly measure and track lesions and nodules in MRI and CT scans SAN FRANCISCO, Feb. 15, 2018 -- (Healthcare Sales & Mark... Devices, Radiology, Oncology, FDA Arterys, imaging, artificial intelligence (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 15, 2018 Category: Pharmaceuticals Source Type: news

GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
WASHINGTON, DC, February 15, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) ("GT" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and commercializat... Biopharmaceuticals, Oncology, Personnel GT Biopharma, lymphoma, leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 15, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Cancer: 'Ultra-processed' foods may increase risk
A new study suggests a possible link between the consumption of ultra-processed foods and raised risk of overall cancer, and breast cancer in particular. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 15, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Obesity May Give Men With Melanoma an Advantage
Among men who received treatment for the potentially deadly cancer, obese patients lived an average of 47 percent longer than those with a healthy body weight, researchers found. (Source: WebMD Health)
Source: WebMD Health - February 15, 2018 Category: Consumer Health News Source Type: news

Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer
Celularity, a company spun out of biotech giant Celgene, announced this morning it has raised $250 million with the aim of developing cells from placentas to attack tumors and to treat Crohn ’s disease. In addition to being awash in cash, the company is flooded with big dreams. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 15, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:CELG NASDAQ:SRNE NASDAQ:UTHR Source Type: news

Despite Need, Cancer Centers Don't Stock Sex Aids Despite Need, Cancer Centers Don't Stock Sex Aids
Low availability of therapeutic sexual aids at NCI-designated cancer centers limits patients'ability to deal with sexual dysfunction in a timely way.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
FRANKFURT (Reuters) - Merck KGaA and Pfizer's cancer drug Bavencio could not be shown to improve survival in lung cancer patients that had previously undergone unsuccessful chemotherapy, Merck said. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Highly Processed Foods Tied to Higher Cancer Risk
Every 10 percent dietary increase in packaged snacks, fizzy drinks, sugary cereals and other highly processed foods boosts the risk for cancer by 12 percent, new research suggests. (Source: WebMD Health)
Source: WebMD Health - February 15, 2018 Category: Consumer Health News Source Type: news

Dr. Theresa Schwartz revamps cancer care at SLU Hospital
Before Theresa Schwartz arrived as a SLUCare physician and surgeon at SSM Health Saint Louis University Hospital, there wasn ’t extensive programming designated to provide care for women with breast cancer and benign breast diseases at the hospital. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2018 Category: Biotechnology Authors: Sabrina Medler Source Type: news

Dr. Theresa Schwartz revamps cancer care at SLU Hospital
Before Theresa Schwartz arrived as a SLUCare physician and surgeon at SSM Health Saint Louis University Hospital, there wasn ’t extensive programming designated to provide care for women with breast cancer and benign breast diseases at the hospital. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - February 15, 2018 Category: Health Management Authors: Sabrina Medler Source Type: news

Why Pig Organs Could Be the Future of Transplants
Making human tissue in a lab has always been more sci-fi than sci-fact, but powerful genetic technologies may change that soon. For the most part, the only way to replace diseased or failing hearts, lungs, kidneys and livers is with donor organs. Even then, many people struggle to find a good biological match with a donor, and 8,000 die each year in the U.S. while waiting for an organ. In one promising solution to the shortage, researchers have been putting a new DNA editing tool called CRISPR through rigorous tests in organ regeneration. Last August, a group of scientists led by George Church, professor of genetics at Har...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime Longevity organ transplants Source Type: news

Amish People Stay Healthy in Old Age. Here ’s Their Secret
Many people think of the Amish as living without. These devout communities, predominantly located in Pennsylvania, Ohio and Indiana, go without cars, TVs, computers, phones or even the electricity needed to run so much of 21st century gadgetry. But what researchers who have studied them have found is what the Amish have a surplus of: good health in late life. The average American life expectancy is currently just under 79 years. Back in 1900, it was only 47, but for early–20th century Amish it was already greater than 70. Over the decades, most Americans have caught up in overall life expectancy, but the Amish still ...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized amish communities healthytime Source Type: news

Inside One Couple ’s Experimental Treatment to Battle Alzheimer’s Disease
JoAnn Wooding is staring intently at the clear liquid dripping from a dark brown IV bag into her husband Peter’s arm. “Please be the drug, please be the drug,” she says. Married for more than 50 years, the Woodings are among the more than 5 million Americans who are facing Alzheimer’s disease, one of the most devastating diagnoses today. But instead of accepting the slow descent into memory loss, confusion and dementia, Peter–who has the disease–could be among the first to successfully stop that decline from happening. Peter, 77, is one of the 2,700 people around the world who are expect...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Alzheimer's Disease healthytime Longevity Source Type: news

NCCN teams up with ASCO to provide guidelines for use of new cancer-fighting drugs
The Montgomery County-based-based National Comprehensive Cancer Network and the American Society of Clinical Oncology have published new guidelines to help clinicians manage side effects related to immune checkpoint inhibitors used in immunotherapy treatments. Immunotherapy, which is revolutionizing the way some cancers are being treated, aims at improving the way a patient's own immune system identifies and attacks invading tumors. Immune checkpoint inhibitors are drugs – often made of antibodies… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

French pharma group Ipsen sees more asset purchases, U.S. growth
PARIS (Reuters) - French pharma company Ipsen expects to bring more drugs to combat cancer, rare diseases and mobility impairment into its pipeline this year and has around one billion euros ($1.25 billion) for asset purchases, its chief executive said. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Another Cancer Vaccine Shows Promise In Mice
THURSDAY, Feb. 15, 2018 -- In what researchers call a first step toward personalized vaccines for a multitude of cancers, a vaccine made from stem cells protected mice from tumors. The vaccine was composed of induced pluripotent stem cells (iPS... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2018 Category: General Medicine Source Type: news

Bristol-Myers Squibb and Nektar Therapeutics announce global development & commercialization collaboration for Nektar's CD122-biased agonist, NKTR-214
Bristol-Myers Squibb Company (NYSE:BMY) and Nektar Therapeutics (Nasdaq:NKTR) announced the companies have executed a global strategic development and commercialization collaboration for Nektar's lead immuno-oncology program, NKTR-214. Under the collaboration, the companies will jointly develop and commercialize NKTR-214 in combination with Bristol-Myers Squibb's Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab) in (Source: World Pharma News)
Source: World Pharma News - February 15, 2018 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

Stem Cell Vaccine Protects Mice From Cancer
Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter. (Source: The Scientist)
Source: The Scientist - February 15, 2018 Category: Science Tags: Daily News,News & Opinion Source Type: news

Highly Processed Foods May Raise Overall Cancer Risk Highly Processed Foods May Raise Overall Cancer Risk
A large cohort study shows that a diet that includes a lot of ultraprocessed food loaded with sugar, salt, and fat was associated with an increased risk for cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Polyp Burden Drops With Sulindac/Erlotinib Combo in FAP
Patients with familial adenomatous polyposis have an increased risk for colorectal polyps and cancer; however, treatment with a combination of sulindac and erlotinib reduced their colorectal polyp burden by more than two thirds. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Genetic Disorders News Source Type: news

Cancer cure? Nanorobots programmed to SHRINK tumours created by scientists
CANCER research scientists have created a nanorobot that can successfully shrink tumours by cutting off their blood supply. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

Living With Cancer: A Cancer Researcher Takes Cancer Personally
Dr. C. Anthony Blau, who has multiple myeloma, started a company to crowdsource an individualized approach to his disease. (Source: NYT Health)
Source: NYT Health - February 15, 2018 Category: Consumer Health News Tags: Breast Cancer Clinical Trials Multiple Myeloma Research Tumors Medicine and Health Source Type: news

City in Alabama sees spike in cancer cases – scientists say it may be from water contaminants
(Natural News) Between 2013 and 2017, the town of Fruithurst in Cleburne County, Alabama, has had eight leukemia diagnoses. Four of those cases were boys under 18 years of age, one of whom has since passed away. Figures have shown that the people of Fruithurst – who number no more than 280 residents – have... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2018 Category: Consumer Health News Source Type: news

Quiz: What Newly Approved Drug Treats Bone Metastases in Multiple Myeloma?
Do you know what dose of carfilzomib is associated with an increased incidence of cardiovascular events in multiple myeloma patients? How about the estimated incidence of new myeloma cases in 2018? Test your knowledge in our latest quiz. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2018 Category: Cancer & Oncology Authors: Cancer Network Editors Tags: Multiple Myeloma Quiz Source Type: news